Brief: Alligator Bioscience: Preliminary Outcome Of Exercise Of Warrants Series TO 13
Sept 16 (Reuters) - Alligator Bioscience AB ATORX.ST: ALLIGATOR BIOSCIENCE AB ANNOUNCES PRELIMINARY OUTCOME OF EXERCISE OF WARRANTS SERIES TO 13 PRELIMINARY OUTCOME THUS INDICATES THAT COMPANY WILL RECEIVE APPROXIMATELY SEK 27.8 MILLION BEFORE ISSUE COSTS. Source text: ID:nMFN7J6355 Further company coverage: ATORX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Alligator Bioscience AB
See all newsBrief: Alligator Bioscience Q1 Net Loss SEK 1.4 Million
Sweden's Alligator Bioscience posts Q1 net profit, narrows operating loss
Brief: Alligator Bioscience Q1 EBIT SEK -17.8 Million
Brief: Alligator Bioscience Signs LoI With Unicancer For Phase 3 Mitazalimab Development
Brief: Exercise Of Warrants Brings Alligator Bioscience Net Proceeds Of SEK 12 Mln